Skip to main content
Top
Published in: BMC Clinical Pathology 1/2012

Open Access 01-12-2012 | Research article

Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: A cross-sectional study

Authors: Shweta Ujaoney, Mukta B Motwani, Shirish Degwekar, Vijay Wadhwan, Prajakta Zade, Minal Chaudhary, Vinay Hazarey, Tushar P Thakre, Manju Mamtani

Published in: BMC Clinical Pathology | Issue 1/2012

Login to get access

Abstract

Background

Early detection holds the key to an effective control of cancers in general and of oral cancers in particular. However, screening procedures for oral cancer are not straightforward due to procedural requirements as well as feasibility issues, especially in resource-limited countries.

Methods

We conducted a cross-sectional study to compare the performance of chemiluminescence, toluidine blue and histopathology for detection of high-risk precancerous oral lesions. We evaluated 99 lesions from 55 patients who underwent chemiluminescence and toluidine blue tests along with biopsy and histopathological examination. We studied inter-as well as intra-rater agreement in the histopathological evaluation and then using latent class modeling, we estimated the operating characteristics of these tests in the absence of a reference standard test.

Results

There was a weak inter-rater agreement (kappa < 0.15) as well as a weak intra-rater reproducibility (Pearson's r = 0.28, intra-class correlation rho = 0.03) in the histopathological evaluation of potentially high-risk precancerous lesions. When compared to histopathology, chemiluminescence and toluidine blue retention had a sensitivity of 1.00 and 0.59, respectively and a specificity of 0.01 and 0.79, respectively. However, latent class analysis indicated a low sensitivity (0.37) and high specificity (0.90) of histopathological evaluation. Toluidine blue had a near perfect high sensitivity and specificity for detection of high-risk lesions.

Conclusion

In our study, there was variability in the histopathological evaluation of oral precancerous lesions. Our results indicate that toluidine blue retention test may be better suited than chemiluminescence to detect high-risk oral precancerous lesions in a high-prevalence and low-resource setting like India.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mignogna MD, Fedele S, Lo Russo L: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev. 2004, 13 (2): 139-142.CrossRefPubMed Mignogna MD, Fedele S, Lo Russo L: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev. 2004, 13 (2): 139-142.CrossRefPubMed
2.
go back to reference Petersen PE: Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol. 2009, 45 (4-5): 454-460. 10.1016/j.oraloncology.2008.05.023.CrossRefPubMed Petersen PE: Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol. 2009, 45 (4-5): 454-460. 10.1016/j.oraloncology.2008.05.023.CrossRefPubMed
3.
go back to reference Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P: A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010, 141 (2): 151-156.CrossRefPubMed Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P: A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010, 141 (2): 151-156.CrossRefPubMed
4.
go back to reference Yeole BB, Sankaranarayanan R, Sunny MSL, Swaminathan R, Parkin DM: Survival from head and neck cancer in Mumbai (Bombay), India. Cancer. 2000, 89 (2): 437-444. 10.1002/1097-0142(20000715)89:2<437::AID-CNCR32>3.0.CO;2-R.CrossRefPubMed Yeole BB, Sankaranarayanan R, Sunny MSL, Swaminathan R, Parkin DM: Survival from head and neck cancer in Mumbai (Bombay), India. Cancer. 2000, 89 (2): 437-444. 10.1002/1097-0142(20000715)89:2<437::AID-CNCR32>3.0.CO;2-R.CrossRefPubMed
5.
go back to reference Sankaranarayanan R: Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India. 2005, 18 (6): 281-284.PubMed Sankaranarayanan R: Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India. 2005, 18 (6): 281-284.PubMed
6.
go back to reference Sankaranarayanan R, Boffetta P: Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol. 2010, 21 (10): 1935-1943. 10.1093/annonc/mdq049.CrossRefPubMed Sankaranarayanan R, Boffetta P: Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol. 2010, 21 (10): 1935-1943. 10.1093/annonc/mdq049.CrossRefPubMed
7.
go back to reference Sankaranarayanan R, Dinshaw K, Nene BM, Ramadas K, Esmy PO, Jayant K, Somanathan T, Shastri S: Cervical and oral cancer screening in India. J Med Screen. 2006, 13 (Suppl 1): S35-S38.PubMed Sankaranarayanan R, Dinshaw K, Nene BM, Ramadas K, Esmy PO, Jayant K, Somanathan T, Shastri S: Cervical and oral cancer screening in India. J Med Screen. 2006, 13 (Suppl 1): S35-S38.PubMed
8.
go back to reference Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E: Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000, 88 (3): 664-673. 10.1002/(SICI)1097-0142(20000201)88:3<664::AID-CNCR25>3.0.CO;2-V.CrossRefPubMed Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E: Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000, 88 (3): 664-673. 10.1002/(SICI)1097-0142(20000201)88:3<664::AID-CNCR25>3.0.CO;2-V.CrossRefPubMed
9.
go back to reference Trullenque-Eriksson A, Munoz-Corcuera M, Campo-Trapero J, Cano-Sanchez J, Bascones-Martinez A: Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal. 2009, 14 (5): E210-E216.PubMed Trullenque-Eriksson A, Munoz-Corcuera M, Campo-Trapero J, Cano-Sanchez J, Bascones-Martinez A: Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal. 2009, 14 (5): E210-E216.PubMed
10.
go back to reference Patton LL, Epstein JB, Kerr AR: Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc. 2008, 139 (7): 896-905. quiz 993-894CrossRefPubMed Patton LL, Epstein JB, Kerr AR: Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc. 2008, 139 (7): 896-905. quiz 993-894CrossRefPubMed
11.
go back to reference Sciubba JJ: Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc. 1999, 130 (10): 1445-1457.CrossRefPubMed Sciubba JJ: Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc. 1999, 130 (10): 1445-1457.CrossRefPubMed
12.
go back to reference Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, Schiff B, Owen RP, Smith J, Sarta C, et al: Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 2010, 34 (5): 676-688.PubMed Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, Schiff B, Owen RP, Smith J, Sarta C, et al: Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 2010, 34 (5): 676-688.PubMed
13.
go back to reference Kerr AR, Sirois DA, Epstein JB: Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent. 2006, 17 (3): 59-63.PubMed Kerr AR, Sirois DA, Epstein JB: Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent. 2006, 17 (3): 59-63.PubMed
14.
go back to reference Ram S, Siar CH: Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg. 2005, 34 (5): 521-527. 10.1016/j.ijom.2004.10.008.CrossRefPubMed Ram S, Siar CH: Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg. 2005, 34 (5): 521-527. 10.1016/j.ijom.2004.10.008.CrossRefPubMed
15.
go back to reference Huff KD: More about cancer detection. J Am Dent Assoc. 2010, 141 (6): 626-628. author reply 628, 630CrossRefPubMed Huff KD: More about cancer detection. J Am Dent Assoc. 2010, 141 (6): 626-628. author reply 628, 630CrossRefPubMed
16.
17.
go back to reference Oliver RJ, MacDonald DG, Felix DH: Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med. 2000, 29 (2): 49-55. 10.1034/j.1600-0714.2000.290201.x.CrossRefPubMed Oliver RJ, MacDonald DG, Felix DH: Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med. 2000, 29 (2): 49-55. 10.1034/j.1600-0714.2000.290201.x.CrossRefPubMed
18.
go back to reference Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E: Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008, 37 (3): 127-133. 10.1111/j.1600-0714.2007.00584.x.CrossRefPubMed Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E: Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008, 37 (3): 127-133. 10.1111/j.1600-0714.2007.00584.x.CrossRefPubMed
19.
go back to reference Dendukuri N, Hadgu A, Wang L: Modeling conditional dependence between diagnostic tests: a multiple latent variable model. Stat Med. 2009, 28 (3): 441-461. 10.1002/sim.3470.CrossRefPubMed Dendukuri N, Hadgu A, Wang L: Modeling conditional dependence between diagnostic tests: a multiple latent variable model. Stat Med. 2009, 28 (3): 441-461. 10.1002/sim.3470.CrossRefPubMed
20.
go back to reference Ihorst G, Forster J, Petersen G, Werchau H, Rohwedder A, Schumacher M: The use of imperfect diagnostic tests had an impact on prevalence estimation. J Clin Epidemiol. 2007, 60 (9): 902-910. 10.1016/j.jclinepi.2006.11.016.CrossRefPubMed Ihorst G, Forster J, Petersen G, Werchau H, Rohwedder A, Schumacher M: The use of imperfect diagnostic tests had an impact on prevalence estimation. J Clin Epidemiol. 2007, 60 (9): 902-910. 10.1016/j.jclinepi.2006.11.016.CrossRefPubMed
21.
go back to reference Koukounari A, Webster JP, Donnelly CA, Bray BC, Naples J, Bosompem K, Shiff C: Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Am J Trop Med Hyg. 2009, 80 (3): 435-441.PubMedPubMedCentral Koukounari A, Webster JP, Donnelly CA, Bray BC, Naples J, Bosompem K, Shiff C: Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Am J Trop Med Hyg. 2009, 80 (3): 435-441.PubMedPubMedCentral
22.
go back to reference Yang I, Becker MP: Latent variable modeling of diagnostic accuracy. Biometrics. 1997, 53 (3): 948-958. 10.2307/2533555.CrossRefPubMed Yang I, Becker MP: Latent variable modeling of diagnostic accuracy. Biometrics. 1997, 53 (3): 948-958. 10.2307/2533555.CrossRefPubMed
23.
go back to reference Bertrand P, Benichou J, Grenier P, Chastang C: Hui and Walter's latent-class reference-free approach may be more useful in assessing agreement than diagnostic performance. J Clin Epidemiol. 2005, 58 (7): 688-700. 10.1016/j.jclinepi.2004.10.021.CrossRefPubMed Bertrand P, Benichou J, Grenier P, Chastang C: Hui and Walter's latent-class reference-free approach may be more useful in assessing agreement than diagnostic performance. J Clin Epidemiol. 2005, 58 (7): 688-700. 10.1016/j.jclinepi.2004.10.021.CrossRefPubMed
24.
go back to reference Albert PS, Dodd LE: On Estimating Diagnostic Accuracy From Studies With Multiple Raters and Partial Gold Standard Evaluation. J Am Stat Assoc. 2008, 103 (481): 61-73. 10.1198/016214507000000329.CrossRefPubMedPubMedCentral Albert PS, Dodd LE: On Estimating Diagnostic Accuracy From Studies With Multiple Raters and Partial Gold Standard Evaluation. J Am Stat Assoc. 2008, 103 (481): 61-73. 10.1198/016214507000000329.CrossRefPubMedPubMedCentral
25.
go back to reference Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM: Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol. 2008, 15 (1): 106-114. 10.1128/CVI.00223-07.CrossRefPubMed Baughman AL, Bisgard KM, Cortese MM, Thompson WW, Sanden GN, Strebel PM: Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol. 2008, 15 (1): 106-114. 10.1128/CVI.00223-07.CrossRefPubMed
26.
go back to reference Chu H, Zhou Y, Cole SR, Ibrahim JG: On the estimation of disease prevalence by latent class models for screening studies using two screening tests with categorical disease status verified in test positives only. Stat Med. 2010, 29 (11): 1206-1218.PubMedPubMedCentral Chu H, Zhou Y, Cole SR, Ibrahim JG: On the estimation of disease prevalence by latent class models for screening studies using two screening tests with categorical disease status verified in test positives only. Stat Med. 2010, 29 (11): 1206-1218.PubMedPubMedCentral
27.
go back to reference Toft N, Jorgensen E, Hojsgaard S: Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard. Prev Vet Med. 2005, 68 (1): 19-33. 10.1016/j.prevetmed.2005.01.006.CrossRefPubMed Toft N, Jorgensen E, Hojsgaard S: Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard. Prev Vet Med. 2005, 68 (1): 19-33. 10.1016/j.prevetmed.2005.01.006.CrossRefPubMed
28.
go back to reference Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM: Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev. 2012, doi: 10.1097/CEJ.0b013e32834fdb6d Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM: Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev. 2012, doi: 10.1097/CEJ.0b013e32834fdb6d
29.
go back to reference Awan KH, Morgan PR, Warnakulasuriya S: Evaluation of an autofluorescence based imaging system (VELscope) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011, 47 (4): 274-277. 10.1016/j.oraloncology.2011.02.001.CrossRefPubMed Awan KH, Morgan PR, Warnakulasuriya S: Evaluation of an autofluorescence based imaging system (VELscope) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011, 47 (4): 274-277. 10.1016/j.oraloncology.2011.02.001.CrossRefPubMed
30.
go back to reference Driemel O, Kunkel M, Hullmann M, von Eggeling F, Muller-Richter U, Kosmehl H, Reichert TE: Diagnosis of oral squamous cell carcinoma and its precursor lesions. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG. 2007, 5 (12): 1095-1100. 10.1111/j.1610-0387.2007.06397.x.CrossRefPubMed Driemel O, Kunkel M, Hullmann M, von Eggeling F, Muller-Richter U, Kosmehl H, Reichert TE: Diagnosis of oral squamous cell carcinoma and its precursor lesions. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG. 2007, 5 (12): 1095-1100. 10.1111/j.1610-0387.2007.06397.x.CrossRefPubMed
31.
go back to reference Seoane Leston J, Diz Dios P: Diagnostic clinical aids in oral cancer. Oral Oncol. 2010, 46 (6): 418-422. 10.1016/j.oraloncology.2010.03.006.CrossRefPubMed Seoane Leston J, Diz Dios P: Diagnostic clinical aids in oral cancer. Oral Oncol. 2010, 46 (6): 418-422. 10.1016/j.oraloncology.2010.03.006.CrossRefPubMed
32.
go back to reference Epstein JB, Silverman S, Epstein JD, Lonky SA, Bride MA: Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008, 44 (6): 538-544. 10.1016/j.oraloncology.2007.08.011.CrossRefPubMed Epstein JB, Silverman S, Epstein JD, Lonky SA, Bride MA: Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008, 44 (6): 538-544. 10.1016/j.oraloncology.2007.08.011.CrossRefPubMed
33.
go back to reference Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H: The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg. 2011, 40 (2): 155-161. 10.1016/j.ijom.2010.10.022.CrossRefPubMed Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H: The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg. 2011, 40 (2): 155-161. 10.1016/j.ijom.2010.10.022.CrossRefPubMed
34.
go back to reference Epstein JB, Guneri P: The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Current opinion in otolaryngology & head and neck surgery. 2009, 17 (2): 79-87. 10.1097/MOO.0b013e32832771da.CrossRef Epstein JB, Guneri P: The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Current opinion in otolaryngology & head and neck surgery. 2009, 17 (2): 79-87. 10.1097/MOO.0b013e32832771da.CrossRef
35.
go back to reference Patton LL: The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol. 2003, 39 (7): 708-723. 10.1016/S1368-8375(03)00083-6.CrossRefPubMed Patton LL: The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol. 2003, 39 (7): 708-723. 10.1016/S1368-8375(03)00083-6.CrossRefPubMed
Metadata
Title
Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: A cross-sectional study
Authors
Shweta Ujaoney
Mukta B Motwani
Shirish Degwekar
Vijay Wadhwan
Prajakta Zade
Minal Chaudhary
Vinay Hazarey
Tushar P Thakre
Manju Mamtani
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2012
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/1472-6890-12-6

Other articles of this Issue 1/2012

BMC Clinical Pathology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.